A Phase I Assessment of the Safety and Tolerability Profile of Novel Treatments for Acute Allergic Reactions Administered by Intravenous and Intramuscular Injection Formulations

Trial Profile

A Phase I Assessment of the Safety and Tolerability Profile of Novel Treatments for Acute Allergic Reactions Administered by Intravenous and Intramuscular Injection Formulations

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2013

At a glance

  • Drugs Cetirizine (Primary) ; Cetirizine (Primary)
  • Indications Asthma; Urticaria
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Feb 2013 New trial record
    • 26 Feb 2013 Results presented at the 69th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top